Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Prolonged vasopressor sup… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Prolonged vasopressor support during hip-fracture surgery is a risk factor for enhanced mortality

Artikel i vetenskaplig tidskrift
Författare J. Kristiansson
Fredrik Olsen
E. Hagberg
Robert Dutkiewicz
Bengt Nellgård
Publicerad i Acta Anaesthesiologica Scandinavica
Volym 63
Nummer/häfte 1
Sidor 46-54
ISSN 0001-5172
Publiceringsår 2019
Publicerad vid Institutionen för kliniska vetenskaper, Avdelningen för anestesiologi och intensivvård
Sidor 46-54
Språk en
Länkar dx.doi.org/10.1111/aas.13215
Ämnesord intraoperative hypotension, noncardiac surgery, myocardial injury, blood-pressure, anesthesia, norepinephrine, association, definition, inotropes, outcomes
Ämneskategorier Anestesiologi

Sammanfattning

Background Hip fracture is a common injury in the elderly population and is associated with high morbidity and mortality. Intraoperative hypotension is commonly noted, and is often treated with vasopressors (VP), however, to what extent is unknown. We set out to examine retrospectively how many hip fracture-patients received VP perioperatively and further to investigate if VP treatment is connected to increased mortality. Method Data on VP treatment were captured from medical and anaesthesia journals, and if so, data were investigated to find potential confounders. Patients were divided into (a) no VP, (b) VP by injection, (c) VP by infusion <3 hours, and (d) VP by infusion >= 3 hours to achieve stratification. Results Nine hundred and ninety-seven patients were included. About 80.4% received VP treatment. The 30-day mortality rates in subgroups were 3.6%, 5.4%, 6.4% and 19.1% respectively. The 90-day mortality rates were 6.7%, 10.3%, 11.6% and 30.3% respectively. Finally, the same patient groups had 365-day mortality rates of 12.8%, 20.0%, 23.3% and 44.9% respectively. We found a significant increase in mortality (30-90-365 days) in patients receiving VP infusion >= 3 hours, after adjusting for confounding factors. There was no increased mortality in patients treated by injection and by infusion Conclusion Vasopressor treatment is common during hip fracture surgery. Patients treated with VP infusion >= 3 hours have increased mortality, while patients treated with injections or infusion

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?